AVR Stock Overview
A structural heart company, designs, develops, and commercializes medical devices.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 1/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Anteris Technologies Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$18.55 |
52 Week High | AU$23.93 |
52 Week Low | AU$15.58 |
Beta | 0.74 |
11 Month Change | -2.27% |
3 Month Change | -21.00% |
1 Year Change | -13.20% |
33 Year Change | 157.64% |
5 Year Change | n/a |
Change since IPO | -75.59% |
Recent News & Updates
Recent updates
Shareholders May Not Be So Generous With Anteris Technologies Ltd's (ASX:AVR) CEO Compensation And Here's Why
May 22Increases to CEO Compensation Might Be Put On Hold For Now at Anteris Technologies Ltd (ASX:AVR)
Jul 08Increases to Anteris Technologies Ltd's (ASX:AVR) CEO Compensation Might Cool off for now
May 07Does Anteris Technologies' (ASX:AVR) CEO Salary Compare Well With The Performance Of The Company?
Feb 21Anteris Technologies Ltd (ASX:AVR) Insiders Have Been Selling
Dec 10Shareholder Returns
AVR | AU Medical Equipment | AU Market | |
---|---|---|---|
7D | -0.3% | 2.9% | -0.1% |
1Y | -13.2% | 24.5% | 8.3% |
Return vs Industry: AVR underperformed the Australian Medical Equipment industry which returned 24.5% over the past year.
Return vs Market: AVR underperformed the Australian Market which returned 8.3% over the past year.
Price Volatility
AVR volatility | |
---|---|
AVR Average Weekly Movement | 3.4% |
Medical Equipment Industry Average Movement | 9.4% |
Market Average Movement | 8.3% |
10% most volatile stocks in AU Market | 16.3% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: AVR's share price has been volatile over the past 3 months.
Volatility Over Time: AVR's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | n/a | Wayne Paterson | www.anteristech.com |
Anteris Technologies Ltd, a structural heart company, designs, develops, and commercializes medical devices. The company manufactures and sells ADAPT, a regenerative tissue product. Its lead product is the DurAVRTM, a transcatheter heart valve for the treatment of aortic stenosis.
Anteris Technologies Ltd Fundamentals Summary
AVR fundamental statistics | |
---|---|
Market cap | AU$356.57m |
Earnings (TTM) | -AU$67.33m |
Revenue (TTM) | AU$4.11m |
86.7x
P/S Ratio-5.3x
P/E RatioIs AVR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AVR income statement (TTM) | |
---|---|
Revenue | AU$4.11m |
Cost of Revenue | AU$1.59m |
Gross Profit | AU$2.52m |
Other Expenses | AU$69.85m |
Earnings | -AU$67.33m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -3.50 |
Gross Margin | 61.23% |
Net Profit Margin | -1,637.85% |
Debt/Equity Ratio | 0% |
How did AVR perform over the long term?
See historical performance and comparison